Cargando…
Targeted Protein Degradation through Cytosolic Delivery of Monobody Binders Using Bacterial Toxins
[Image: see text] Monobodies are small engineered binding proteins that, upon expression in cells, can inhibit signaling of cytosolic oncoproteins with outstanding selectivity. Efficacy may be further increased by inducing degradation of monobody targets through fusion to the von Hippel–Lindau (VHL)...
Autores principales: | Schmit, Nadine Eliane, Neopane, Katyayanee, Hantschel, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316569/ https://www.ncbi.nlm.nih.gov/pubmed/31025848 http://dx.doi.org/10.1021/acschembio.9b00113 |
Ejemplares similares
-
Selective Targeting of SH2 Domain–Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies
por: Kükenshöner, Tim, et al.
Publicado: (2017) -
Monobodies as possible next-generation protein therapeutics – a perspective
por: Oliver, Hantschel
Publicado: (2017) -
Tuning SAS-6 architecture with monobodies impairs distinct steps of centriole assembly
por: Hatzopoulos, Georgios N., et al.
Publicado: (2021) -
Selective inhibition of STAT3 signaling using monobodies targeting the coiled-coil and N-terminal domains
por: La Sala, Grégory, et al.
Publicado: (2020) -
Monobody adapter for functional antibody display on nanoparticles for adaptable targeted delivery applications
por: Albert, C., et al.
Publicado: (2022)